Skip to product information
1 of 1
Regular price £96.79 GBP
Regular price £118.00 GBP Sale price £96.79 GBP
Sale Sold out
Free UK Shipping

Freshly Printed - allow 10 days lead

Cancer Vaccines as Immunotherapy of Cancer

Presents recent findings in the field of cancer vaccines focusing on both research and clinical aspects

Luigi Buonaguro (Edited by), Sjoerd Van Der Burg (Edited by)

9780128239018

Paperback, published 23 March 2022

272 pages, 30 illustrations (15 in full color)
22.9 x 15.1 x 1.8 cm, 0.43 kg

Cancer Vaccines as Immunotherapy of Cancer provides extensive and state-of-the-art information about the meaning, relevance and limitation of therapeutic cancer vaccines. It covers all the aspects involved in the vaccine research and development (identification of optimal target antigens, formulations, delivery strategies, adjuvants among others) as well as their use in combination with other immunomodulatory approaches.

The book discusses topics such as identification of tumor associated and specific antigens, proteogenomic for identification of novel target tumor antigens, antigen-specific T cells, and Peptide and RNA based vaccines. Additionally, it covers oncolytic viruses for antigen delivery, cancer vaccine targeting viral antigens and combinatorial immunotherapy strategies.

Written by leading experts worldwide, this is a valuable resource for cancer researchers, oncologists and members of biomedical field who wants to understand in depth the recent findings in the field of cancer vaccines.

1. Introduction2. Identification of Tumor Associated Antigens3. Identification of Tumor Specific Antigens4. Proteogenomics for identification of novel target tumor antigens5. Antigen-specific T cells6. Tumor antigens for preventive strategies7. Peptide based vaccines8. RNA based vaccines9. Novel dendritic cells strategies10. Oncolytic viruses for antigen delivery11. Cancer vaccine targeting viral antigens12. Combinatorial immunotherapy strategies13. Conclusions

Subject Areas: Life sciences: general issues [PSA]

View full details